Efficacy and safety of ainuovirine versus efavirenz combination therapies with lamivudine/tenofovir disoproxil fumarate for medication of treatment-naïve HIV-1-positive adults: week 48 results of a randomized controlled phase 3 clinical trial followed by an open-label setting until week 96.
Su B, Gao G, Wang M, Lu Y, Li L, Chen C, Chen Y, Song C, Yu F, Li Y, Liu Y, Luo Y, He H, Cheng C, Xu L, Zhang T, Sun L, Liu A, Xia W, Qin Y, Zhao Q, Wei H, Cai W, Chen Y, Zhang F, Wu H.
Su B, et al. Among authors: chen c, chen y.
Lancet Reg Health West Pac. 2023 Apr 24;36:100769. doi: 10.1016/j.lanwpc.2023.100769. eCollection 2023 Jul.
Lancet Reg Health West Pac. 2023.
PMID: 37547039
Free PMC article.